Bellevue Group’s Summit Therapeutics SMMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$888K	Sell	41,738 -25,947	-38%	-$552K	0.02%	106
2025 Q1	$1.31M	Sell	67,685 -102,909	-60%	-$1.99M	0.03%	104
2024 Q4	$3.04M	Buy	170,594 +106,500	+166%	+$1.9M	0.06%	102
2024 Q3	$1.4M	Buy	+64,094	New	+$1.4M	0.02%	110